|
|

Public health policies have changed dramatically over the three decades that Dr. Mullooly, Senior Investigator in biostatistics, has worked at the CHR. When he joined CHR, his areas of research, infectious disease epidemiology and vaccinations, focused on vaccine effectiveness and vaccination policy issues that promoted their widespread use. His research demonstrated for the first time that influenza vaccination programs for the elderly, especially the high-risk elderly, actually improved health for Kaiser Permanente members and produced a cost saving. It was an important contribution to Medicare's policy decision to cover the elderly for flu vaccinations.
Some of his past work attempted to evaluate the costs, in terms of illness and medical treatment and other factors such as lost days of productivity at work, of possible side effects of various vaccines. He examined the potential side effects of certain vaccines, which have to be factored into the cost-benefit ratio of any vaccine. Now, Dr. Mullooly still contributes as an investigator on studies of well-established childhood vaccines, adult immunizations, and cancer epidemiology. He is studying the varicella vaccine (for chicken pox), using mathematical models to predict the effects on herpes zoster (painful shingles) over the next 20 years. Dr. Mullooly received his PhD in mathematical statistics from Catholic University of America.
Current Studies:
Recently Completed Studies:
E-mail:
John.Mullooly@kpchr.org
|